NKTR logo

NKTR
Nektar Therapeutics

8,792
Mkt Cap
$2.22B
Volume
446,234.00
52W High
$78.95
52W Low
$7.99
PE Ratio
-7.58
NKTR Fundamentals
Price
$77.50
Prev Close
$77.85
Open
$78.36
50D MA
$66.19
Beta
1.85
Avg. Volume
918,248.55
EPS (Annual)
-$9.73
P/B
17.58
Rev/Employee
$876,698.41
$616.46
Loading...
Loading...
News
all
press releases
Nektar Therapeutics (NASDAQ:NKTR) Rating Increased to Hold at Wall Street Zen
Wall Street Zen raised Nektar Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·20h ago
News Placeholder
More News
News Placeholder
NKTR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026
NKTR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 NKTR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 PR Newswire NEW...
PR Newswire·1d ago
News Placeholder
Nektar Therapeutics (NASDAQ:NKTR) Reaches New 12-Month High - Still a Buy?
Nektar Therapeutics (NASDAQ:NKTR) Hits New 52-Week High - What's Next...
MarketBeat·1d ago
News Placeholder
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit PR Newswire NEW YORK, April...
PR Newswire·2d ago
News Placeholder
Nektar Therapeutics (NKTR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Nektar Therapeutics (NKTR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit Nektar Therapeutics (NKTR) Shareholders Who Lost Money Have Opportunity to Lead Securities...
PR Newswire·2d ago
News Placeholder
Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers - NKTR
Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers - NKTR Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar...
PR Newswire·2d ago
News Placeholder
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) have earned an average recommendation of "Moderate Buy" from the eleven ratings firms that are currently covering the stock, Marketbeat...
MarketBeat·3d ago
News Placeholder
NKTR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Nektar Therapeutics Securities Lawsuit -- The Gross Law Firm
NKTR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Nektar Therapeutics Securities Lawsuit -- The Gross Law Firm NKTR Shareholder Alert: Investors With Losses May Seek...
PR Newswire·5d ago
News Placeholder
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with...
PR Newswire·6d ago
News Placeholder
Nektar Therapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NKTR
Nektar Therapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NKTR Nektar Therapeutics Sued for Securities Law Violations - Contact the DJS Law Group to...
PR Newswire·6d ago
<
1
2
...
>

Latest NKTR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.